Log in to save to my catalogue

PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade ra...

PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade ra...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6e2b77747e884b2d9b01fa05018ce46e

PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy

About this item

Full title

PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy

Publisher

England: BioMed Central

Journal title

Cell & bioscience, 2022-04, Vol.12 (1), p.50-50, Article 50

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Despite advances in treatment of patients with non-small cell lung cancer, carriers of certain genetic alterations are prone to failure. One such factor frequently mutated, is the tumor suppressor PTEN. These tumors are supposed to be more resistant to radiation, chemo- and immunotherapy.
We demonstrate that loss of PTEN led to altered expressio...

Alternative Titles

Full title

PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6e2b77747e884b2d9b01fa05018ce46e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6e2b77747e884b2d9b01fa05018ce46e

Other Identifiers

ISSN

2045-3701

E-ISSN

2045-3701

DOI

10.1186/s13578-022-00778-7

How to access this item